RankingsPricing
  1. JP-listed companies
  2. Delta-Fly Pharma, Inc.
  3. Financials
  4. Stockholders' equity

Delta-Fly Pharma, Inc.【JP:4598】

Market cap
¥4.9B
P/E ratio
-2.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2025278-77.46%
Mar 31, 20241,233+55.80%
Mar 31, 2023791-35.84%
Mar 31, 20221,233-40.68%
Mar 31, 20212,079+1.10%
Mar 31, 20202,056-41.32%
Mar 31, 20193,504+326.03%
Mar 31, 2018822+6.99%
Mar 31, 2017769

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)